News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,152 Results
Type
Article (13759)
Company Profile (101)
Press Release (251292)
Section
Business (88036)
Career Advice (465)
Deals (15342)
Drug Delivery (67)
Drug Development (36602)
Employer Resources (49)
FDA (6288)
Job Trends (6196)
News (150202)
Policy (14025)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (440)
Adcomms (6)
Allergies (32)
Alliances (23211)
ALS (36)
Alzheimer's disease (386)
Antibody-drug conjugate (ADC) (36)
Approvals (6326)
Artificial intelligence (101)
Autoimmune disease (7)
Automation (3)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (55)
Biotechnology (40)
Bladder cancer (19)
Brain cancer (15)
Breast cancer (74)
Cancer (580)
Cardiovascular disease (70)
Career advice (407)
Career pathing (11)
CAR-T (20)
Cell therapy (83)
Cervical cancer (4)
Clinical research (30873)
Collaboration (323)
Compensation (134)
Complete response letters (17)
COVID-19 (757)
CRISPR (19)
C-suite (117)
Cystic fibrosis (35)
Data (598)
Denatured (15)
Depression (9)
Diabetes (77)
Diagnostics (1316)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (55)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (33)
Earnings (32073)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37388)
Executive appointments (356)
FDA (6680)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (204)
Gene editing (37)
Generative AI (8)
Gene therapy (99)
GLP-1 (340)
Government (1285)
Grass and pollen (2)
Guidances (15)
Healthcare (3564)
Huntington's disease (4)
IgA nephropathy (10)
Immunology and inflammation (34)
Indications (12)
Infectious disease (789)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (45)
Interviews (59)
IPO (5874)
IRA (29)
Job creations (2050)
Job search strategy (373)
Kidney cancer (6)
Labor market (10)
Layoffs (177)
Leadership (3)
Legal (3429)
Liver cancer (19)
Lung cancer (78)
Lymphoma (52)
Machine learning (1)
Management (16)
Manufacturing (142)
MASH (31)
Medical device (1275)
Medtech (1277)
Mergers & acquisitions (9655)
Metabolic disorders (247)
Multiple sclerosis (19)
NASH (14)
Neurodegenerative disease (22)
Neuropsychiatric disorders (6)
Neuroscience (555)
NextGen: Class of 2025 (1586)
Non-profit (593)
Northern California (676)
Now hiring (7)
Obesity (141)
Opinion (118)
Ovarian cancer (21)
Pain (50)
Pancreatic cancer (13)
Parkinson's disease (42)
Partnered (7)
Patents (104)
Patient recruitment (28)
Peanut (10)
People (28867)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8035)
Phase II (13059)
Phase III (11726)
Pipeline (407)
Podcasts (46)
Policy (58)
Postmarket research (1401)
Preclinical (3207)
Press Release (25)
Prostate cancer (44)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (158)
Real estate (2633)
Recruiting (17)
Regulatory (10085)
Reports (14)
Research institute (564)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (7)
Schizophrenia (35)
Series A (35)
Series B (11)
Service/supplier (3)
Sickle cell disease (31)
Southern California (691)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1627)
State (2)
Stomach cancer (3)
Supply chain (28)
The Weekly (28)
United States (6841)
Vaccines (150)
Venture capitalists (13)
Webinars (10)
Weight loss (95)
Women's health (8)
Worklife (3)
Date
Today (82)
Last 7 days (255)
Last 30 days (978)
Last 365 days (12101)
2025 (3009)
2024 (12502)
2023 (14247)
2022 (19557)
2021 (20068)
2020 (19032)
2019 (14885)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (54)
Arkansas (3)
Asia (20088)
Australia (2603)
California (1632)
Canada (872)
China (228)
Colorado (65)
Connecticut (65)
Delaware (53)
Europe (39353)
Florida (304)
Georgia (36)
Idaho (9)
Illinois (185)
India (14)
Indiana (128)
Iowa (1)
Japan (86)
Kansas (55)
Kentucky (12)
Maine (2)
Maryland (245)
Massachusetts (1407)
Michigan (28)
Minnesota (89)
Mississippi (1)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (718)
New Mexico (7)
New York (475)
North Carolina (378)
North Dakota (2)
Northern California (676)
Ohio (48)
Oklahoma (4)
Oregon (16)
Pennsylvania (412)
Puerto Rico (8)
Rhode Island (7)
South America (501)
South Carolina (2)
Southern California (691)
Tennessee (34)
Texas (218)
Utah (33)
Virginia (69)
Washington D.C. (29)
Washington State (111)
Wisconsin (14)
265,152 Results for "reviva pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
April 1, 2025
·
9 min read
Press Releases
Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress
March 31, 2025
·
1 min read
Press Releases
Reviva to Participate in the 2025 BIO CEO & Investor Conference
January 30, 2025
·
1 min read
Press Releases
Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
1 min read
Biotech Bay
Reviva to Participate in the BIO International Convention 2024
Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a panel discussion at the BIO International Convention, taking place June 3-6, 2024, in San Diego, CA.
May 21, 2024
·
1 min read
Press Releases
Reviva Announces Proposed Public Offering
December 17, 2024
·
4 min read
Press Releases
Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit
January 8, 2025
·
1 min read
Biotech Bay
Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”) today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the 2024 BIO CEO & Investor Conference, taking place February 26-27, 2024, in New York, NY.
February 20, 2024
·
1 min read
Biotech Bay
Reviva to Present at the UBS Virtual CNS Day
Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a Fireside Chat at the UBS Virtual CNS Day, taking place virtually March 18, 2024.
March 11, 2024
·
1 min read
Business
Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights
Reviva Pharmaceuticals Holdings, Inc. today reported financial results for the first quarter ended March 31, 2024 and summarized recent business highlights.
May 14, 2024
·
9 min read
1 of 26,516
Next
